Is the Fed Put Back in Play, and What’s Next for Biogen? 9/28/22
Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.
More description
Stocks rallying after hitting the year’s lows as one central bank indicated it’s willing to step in to calm the markets. But will the Fed follow suit or is there more turmoil ahead? Plus Biogen making a major breakthrough with its Alzheimer’s treatment. What it means for the stock and the rest of the biotech space.
2022-09-28
43 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.